SynthesisScientific reports2018

The benefits of modified FOLFIRINOX for advanced pancreatic cancer and its induced adverse events: a systematic review and meta-analysis.

Hongxuan Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.